Apogee Therapeutics shares owned by Deutsche Bank Aktiengesellschaft
Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by Deutsche Bank Aktiengesellschaft
from 13F filings
Historical chart of Deutsche Bank Aktiengesellschaft investment in Apogee Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Apogee Therapeutics held by Deutsche Bank Aktiengesellschaft consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Apogee Therapeutics by Deutsche Bank Aktiengesellschaft
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $3.0M | 77k | 39.73 |
| 2025-06-30 | $1.0M | 24k | 43.43 |
| 2025-03-31 | $1.1M | 29k | 37.36 |
| 2024-12-31 | $1.4M | 32k | 45.30 |
| 2024-09-30 | $1.2M | 21k | 58.74 |
| 2024-06-30 | $637k | 16k | 39.35 |
| 2024-03-31 | $1.3M | 19k | 66.45 |
| 2023-12-31 | $214k | 7.7k | 27.94 |
| 2023-09-30 | $98k | 4.6k | 21.30 |
More positions owned by Deutsche Bank Aktiengesellschaft
View all positions for Deutsche Bank Aktiengesellschaft